Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2. (Q36648790)
Jump to navigation
Jump to search
scientific article published on March 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2. |
scientific article published on March 2003 |
Statements
1 reference
Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2. (English)
1 reference
B J Allen
1 reference
Z Tian
1 reference
S M A Rizvi
1 reference
Y Li
1 reference
M Ranson
1 reference
1 March 2003
1 reference
1 reference
944-950
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference